Traditional Chinese medicine for resisting hyperostosis

Abstract

The invention discloses a traditional Chinese medicine for resisting hyperostosis. The traditional Chinese medicine is characterized by consisting of the following components: radix rehmanniae praeparata, drynaria rhizome, roasted semen strychni, caulis spatholobi, herba cistanches, herb of sedum aizoon L., frankincense, myrrh and rhizoma ligustici wallichii; the percentages of the components are as follows: 10-18% of the radix rehmanniae praeparata, 10-18% of the drynaria rhizome, 10-18% of the roasted semen strychni, 10-18% of the caulis spatholobi, 10-18% of the herba cistanches, 5-9% of herb of sedum aizoon L., 5-9% of the frankincense, 5-9% of the myrrh and 5-9% of the rhizoma ligustici wallichii; and a preparation method of the traditional Chinese medicine comprises the following steps: weighing the nine medicinal materials, crushing the medicinal materials into fine powder and refining the fine powder with honey so as to obtain pills, wherein each pill is 6g in weight. The traditional Chinese medicine can solve the problem that analgesic and anti-inflammatory medicines, which are adopted by modern medicine for treating the hyperostosis, fail to achieve radical treatment; and the traditional Chinese medicine is suitable for treating the hyperostosis.

Description

Technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine prescription for anti-osteogeny. technical background [0002] Osteoarthritis is also known as hyperplastic osteoarthritis, osteoarthritis, degenerative joint disease, senile arthritis, and hypertrophic arthritis. Bone spurs are formed on the edge, synovial hypertrophy and other changes, resulting in bone destruction, causing secondary bone hyperplasia, resulting in joint deformation. When subjected to abnormal loads, it causes joint pain and limited mobility. Divided into cervical hyperosteogeny, lumbar hyperosteogeny, knee hyperosteogeny, fingertip degenerative disease, root bone spur, etc. The treatment of modern medicine to this disease usually adopts anti-inflammatory and analgesic drugs, which cannot be eradicated. Contents of the invention [0003] In order to solve the problem that modern medical treatment of hypero...

AI Technical Summary

Problems solved by technology

[0003] In order to solve the problem that modern medical treatment of hyperosteogeny cannot be eradicated by using anti-inflammatory and analgesic drugs, the invention is a traditional Chinese medicine for anti-osteogeny. Seedlings, Caulis Spatholobus, Cistanche, Panax notoginseng, Frankincense, Myrrh, Chuanxiong; component ratio: rehmannia glutinosa 10-18%, drynaria 10-18%, sunburst 10-18%, Caulis Spatholobus 10-18%, Cistanche 10-18%, Panax notoginseng 5-9%, Frankincense 5-9%, Myrrh 5-9%, Chuanxiong 5-9%